EP15R_HUMAN - dbPTM
EP15R_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID EP15R_HUMAN
UniProt AC Q9UBC2
Protein Name Epidermal growth factor receptor substrate 15-like 1
Gene Name EPS15L1
Organism Homo sapiens (Human).
Sequence Length 864
Subcellular Localization Cell membrane
Peripheral membrane protein. Nucleus. Membrane, coated pit. Localized to plasma membrane coated pits..
Protein Description Seems to be a constitutive component of clathrin-coated pits that is required for receptor-mediated endocytosis. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2..
Protein Sequence MAAPLIPLSQQIPTGNSLYESYYKQVDPAYTGRVGASEAALFLKKSGLSDIILGKIWDLADPEGKGFLDKQGFYVALRLVACAQSGHEVTLSNLNLSMPPPKFHDTSSPLMVTPPSAEAHWAVRVEEKAKFDGIFESLLPINGLLSGDKVKPVLMNSKLPLDVLGRVWDLSDIDKDGHLDRDEFAVAMHLVYRALEKEPVPSALPPSLIPPSKRKKTVFPGAVPVLPASPPPKDSLRSTPSHGSVSSLNSTGSLSPKHSLKQTQPTVNWVVPVADKMRFDEIFLKTDLDLDGYVSGQEVKEIFMHSGLTQNLLAHIWALADTRQTGKLSKDQFALAMYFIQQKVSKGIDPPQVLSPDMVPPSERGTPGPDSSGSLGSGEFTGVKELDDISQEIAQLQREKYSLEQDIREKEEAIRQKTSEVQELQNDLDRETSSLQELEAQKQDAQDRLDEMDQQKAKLRDMLSDVRQKCQDETQMISSLKTQIQSQESDLKSQEDDLNRAKSELNRLQQEETQLEQSIQAGRVQLETIIKSLKSTQDEINQARSKLSQLHESRQEAHRSLEQYDQVLDGAHGASLTDLANLSEGVSLAERGSFGAMDDPFKNKALLFSNNTQELHPDPFQTEDPFKSDPFKGADPFKGDPFQNDPFAEQQTTSTDPFGGDPFKESDPFRGSATDDFFKKQTKNDPFTSDPFTKNPSLPSKLDPFESSDPFSSSSVSSKGSDPFGTLDPFGSGSFNSAEGFADFSQMSKPPPSGPFTSSLGGAGFSDDPFKSKQDTPALPPKKPAPPRPKPPSGKSTPVSQLGSADFPEAPDPFQPLGADSGDPFQSKKGFGDPFSGKDPFVPSSAAKPSKASASGFADFTSVS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAPLIPLS
------CCCCCCCHH
20.1419413330
9PhosphorylationAAPLIPLSQQIPTGN
CCCCCCHHHCCCCCC
18.0629083192
14PhosphorylationPLSQQIPTGNSLYES
CHHHCCCCCCCHHHH
51.1028348404
17PhosphorylationQQIPTGNSLYESYYK
HCCCCCCCHHHHHHC
33.4028348404
19PhosphorylationIPTGNSLYESYYKQV
CCCCCCHHHHHHCCC
11.5828348404
21PhosphorylationTGNSLYESYYKQVDP
CCCCHHHHHHCCCCH
21.8725627689
22PhosphorylationGNSLYESYYKQVDPA
CCCHHHHHHCCCCHH
11.6225627689
30PhosphorylationYKQVDPAYTGRVGAS
HCCCCHHHCCCCCHH
18.3425147952
46PhosphorylationAALFLKKSGLSDIIL
HHHHHHHCCCCHHHH
43.3030266825
46 (in isoform 2)Phosphorylation-43.3027251275
49PhosphorylationFLKKSGLSDIILGKI
HHHHCCCCHHHHHHH
30.2330266825
49 (in isoform 2)Phosphorylation-30.2327251275
74PhosphorylationFLDKQGFYVALRLVA
CCCCCCHHHHHHHHH
7.5228152594
90PhosphorylationAQSGHEVTLSNLNLS
HHCCCEEEEECCCCC
22.8326074081
92PhosphorylationSGHEVTLSNLNLSMP
CCCEEEEECCCCCCC
29.8826074081
97PhosphorylationTLSNLNLSMPPPKFH
EEECCCCCCCCCCCC
28.3326074081
106PhosphorylationPPPKFHDTSSPLMVT
CCCCCCCCCCCEEEC
23.6422167270
106 (in isoform 2)Phosphorylation-23.6427251275
107PhosphorylationPPKFHDTSSPLMVTP
CCCCCCCCCCEEECC
35.7022167270
108PhosphorylationPKFHDTSSPLMVTPP
CCCCCCCCCEEECCC
24.9322167270
108 (in isoform 2)Phosphorylation-24.9327251275
113PhosphorylationTSSPLMVTPPSAEAH
CCCCEEECCCCCHHE
18.6025159151
113 (in isoform 2)Phosphorylation-18.6027251275
116PhosphorylationPLMVTPPSAEAHWAV
CEEECCCCCHHEEEE
39.6925159151
146PhosphorylationLPINGLLSGDKVKPV
CCCCCCCCCCCCCCC
50.4125867546
171PhosphorylationLGRVWDLSDIDKDGH
HHCCCCHHHCCCCCC
30.01-
202PhosphorylationLEKEPVPSALPPSLI
HHHCCCCCCCCHHHC
42.5528509920
207PhosphorylationVPSALPPSLIPPSKR
CCCCCCHHHCCCCCC
36.6728509920
212PhosphorylationPPSLIPPSKRKKTVF
CHHHCCCCCCCCCCC
39.4728509920
217PhosphorylationPPSKRKKTVFPGAVP
CCCCCCCCCCCCCEE
30.3423927012
229PhosphorylationAVPVLPASPPPKDSL
CEEECCCCCCCCCCC
35.6829255136
229 (in isoform 2)Phosphorylation-35.6827251275
235PhosphorylationASPPPKDSLRSTPSH
CCCCCCCCCCCCCCC
31.6330278072
238PhosphorylationPPKDSLRSTPSHGSV
CCCCCCCCCCCCCCC
50.3825159151
239PhosphorylationPKDSLRSTPSHGSVS
CCCCCCCCCCCCCCC
23.5223927012
241PhosphorylationDSLRSTPSHGSVSSL
CCCCCCCCCCCCCCC
40.3425159151
241 (in isoform 2)Phosphorylation-40.3427251275
244PhosphorylationRSTPSHGSVSSLNST
CCCCCCCCCCCCCCC
17.2525159151
244 (in isoform 2)Phosphorylation-17.2527251275
246PhosphorylationTPSHGSVSSLNSTGS
CCCCCCCCCCCCCCC
30.7023927012
246 (in isoform 2)Phosphorylation-30.7027251275
247PhosphorylationPSHGSVSSLNSTGSL
CCCCCCCCCCCCCCC
29.4323927012
247 (in isoform 2)Phosphorylation-29.4327251275
250PhosphorylationGSVSSLNSTGSLSPK
CCCCCCCCCCCCCCC
39.1625159151
250 (in isoform 2)Phosphorylation-39.1627251275
251PhosphorylationSVSSLNSTGSLSPKH
CCCCCCCCCCCCCCC
29.7123927012
253PhosphorylationSSLNSTGSLSPKHSL
CCCCCCCCCCCCCCC
26.2622167270
253 (in isoform 2)Phosphorylation-26.2627251275
255PhosphorylationLNSTGSLSPKHSLKQ
CCCCCCCCCCCCCCC
33.3322167270
255 (in isoform 2)Phosphorylation-33.3327251275
259PhosphorylationGSLSPKHSLKQTQPT
CCCCCCCCCCCCCCC
43.3123401153
261UbiquitinationLSPKHSLKQTQPTVN
CCCCCCCCCCCCCEE
55.07-
263PhosphorylationPKHSLKQTQPTVNWV
CCCCCCCCCCCEEEE
34.6228857561
293PhosphorylationTDLDLDGYVSGQEVK
CCCCCCCCCCHHHHH
7.3625147952
295PhosphorylationLDLDGYVSGQEVKEI
CCCCCCCCHHHHHHH
26.6927251275
355PhosphorylationIDPPQVLSPDMVPPS
CCCCCCCCCCCCCCH
21.7225159151
362PhosphorylationSPDMVPPSERGTPGP
CCCCCCCHHCCCCCC
33.5825159151
362 (in isoform 2)Phosphorylation-33.5827251275
366PhosphorylationVPPSERGTPGPDSSG
CCCHHCCCCCCCCCC
31.1519664994
366 (in isoform 2)Phosphorylation-31.1527251275
371PhosphorylationRGTPGPDSSGSLGSG
CCCCCCCCCCCCCCC
39.4729255136
372PhosphorylationGTPGPDSSGSLGSGE
CCCCCCCCCCCCCCC
39.5229255136
374PhosphorylationPGPDSSGSLGSGEFT
CCCCCCCCCCCCCCC
31.3529255136
374 (in isoform 2)Phosphorylation-31.3527251275
377PhosphorylationDSSGSLGSGEFTGVK
CCCCCCCCCCCCCCC
40.2029255136
377 (in isoform 2)Phosphorylation-40.2027251275
381PhosphorylationSLGSGEFTGVKELDD
CCCCCCCCCCCCHHH
36.4429255136
384UbiquitinationSGEFTGVKELDDISQ
CCCCCCCCCHHHHHH
54.63-
390PhosphorylationVKELDDISQEIAQLQ
CCCHHHHHHHHHHHH
28.8425159151
390 (in isoform 2)Phosphorylation-28.8427251275
400UbiquitinationIAQLQREKYSLEQDI
HHHHHHHHHCHHHHH
42.18-
401PhosphorylationAQLQREKYSLEQDIR
HHHHHHHHCHHHHHH
17.4629214152
401 (in isoform 2)Phosphorylation-17.4627642862
402PhosphorylationQLQREKYSLEQDIRE
HHHHHHHCHHHHHHH
36.1825159151
402 (in isoform 2)Phosphorylation-36.1827251275
417UbiquitinationKEEAIRQKTSEVQEL
HHHHHHHHHHHHHHH
44.14-
418PhosphorylationEEAIRQKTSEVQELQ
HHHHHHHHHHHHHHH
23.06-
432PhosphorylationQNDLDRETSSLQELE
HHHHHHHHHHHHHHH
25.2226657352
433PhosphorylationNDLDRETSSLQELEA
HHHHHHHHHHHHHHH
25.0525850435
434PhosphorylationDLDRETSSLQELEAQ
HHHHHHHHHHHHHHH
41.3025849741
434 (in isoform 2)Phosphorylation-41.3027251275
462SulfoxidationQKAKLRDMLSDVRQK
HHHHHHHHHHHHHHH
2.8921406390
478PhosphorylationQDETQMISSLKTQIQ
HHHHHHHHHHHHHHH
25.0324719451
482PhosphorylationQMISSLKTQIQSQES
HHHHHHHHHHHHHHH
35.8821601212
486PhosphorylationSLKTQIQSQESDLKS
HHHHHHHHHHHHHHH
37.2325159151
486 (in isoform 2)Phosphorylation-37.2327251275
489PhosphorylationTQIQSQESDLKSQED
HHHHHHHHHHHHHHH
40.3822817901
492UbiquitinationQSQESDLKSQEDDLN
HHHHHHHHHHHHHHH
55.9021890473
492 (in isoform 2)Ubiquitination-55.90-
518PhosphorylationEETQLEQSIQAGRVQ
HHHHHHHHHHHCCHH
13.8028555341
528PhosphorylationAGRVQLETIIKSLKS
HCCHHHHHHHHHHHC
36.2720068231
531UbiquitinationVQLETIIKSLKSTQD
HHHHHHHHHHHCCHH
45.9821890473
531UbiquitinationVQLETIIKSLKSTQD
HHHHHHHHHHHCCHH
45.9821890473
531UbiquitinationVQLETIIKSLKSTQD
HHHHHHHHHHHCCHH
45.9821890473
531UbiquitinationVQLETIIKSLKSTQD
HHHHHHHHHHHCCHH
45.9821890473
531 (in isoform 2)Ubiquitination-45.98-
534UbiquitinationETIIKSLKSTQDEIN
HHHHHHHHCCHHHHH
59.5621906983
534 (in isoform 2)Ubiquitination-59.56-
546AcetylationEINQARSKLSQLHES
HHHHHHHHHHHHHHH
46.7525953088
546UbiquitinationEINQARSKLSQLHES
HHHHHHHHHHHHHHH
46.75-
546 (in isoform 2)Ubiquitination-46.75-
548PhosphorylationNQARSKLSQLHESRQ
HHHHHHHHHHHHHHH
34.1429214152
553PhosphorylationKLSQLHESRQEAHRS
HHHHHHHHHHHHHHH
28.6328555341
560PhosphorylationSRQEAHRSLEQYDQV
HHHHHHHHHHHHHHH
26.7925159151
560 (in isoform 2)Phosphorylation-26.7927642862
564PhosphorylationAHRSLEQYDQVLDGA
HHHHHHHHHHHHHHC
10.0428176443
564 (in isoform 2)Phosphorylation-10.0427642862
575PhosphorylationLDGAHGASLTDLANL
HHHCCCCCHHHHHHH
36.0725159151
575 (in isoform 2)Phosphorylation-36.0727642862
577PhosphorylationGAHGASLTDLANLSE
HCCCCCHHHHHHHHH
26.8625159151
583PhosphorylationLTDLANLSEGVSLAE
HHHHHHHHHCCCHHH
31.9228450419
583 (in isoform 2)Phosphorylation-31.9227251275
587PhosphorylationANLSEGVSLAERGSF
HHHHHCCCHHHHCCC
32.4925627689
593PhosphorylationVSLAERGSFGAMDDP
CCHHHHCCCCCCCCC
27.0823401153
593 (in isoform 2)Phosphorylation-27.0827251275
593 (in isoform 4)Phosphorylation-27.0827251275
597SulfoxidationERGSFGAMDDPFKNK
HHCCCCCCCCCCCCC
6.5021406390
602UbiquitinationGAMDDPFKNKALLFS
CCCCCCCCCCEEEEC
64.0321890473
602UbiquitinationGAMDDPFKNKALLFS
CCCCCCCCCCEEEEC
64.0321890473
602UbiquitinationGAMDDPFKNKALLFS
CCCCCCCCCCEEEEC
64.0321890473
604UbiquitinationMDDPFKNKALLFSNN
CCCCCCCCEEEECCC
40.7921890473
604UbiquitinationMDDPFKNKALLFSNN
CCCCCCCCEEEECCC
40.7921890473
604UbiquitinationMDDPFKNKALLFSNN
CCCCCCCCEEEECCC
40.7921890473
604 (in isoform 2)Ubiquitination-40.79-
609PhosphorylationKNKALLFSNNTQELH
CCCEEEECCCCCCCC
29.1926074081
612PhosphorylationALLFSNNTQELHPDP
EEEECCCCCCCCCCC
27.8922199227
612 (in isoform 2)Phosphorylation-27.8927251275
627UbiquitinationFQTEDPFKSDPFKGA
CCCCCCCCCCCCCCC
60.3821890473
627 (in isoform 2)Ubiquitination-60.38-
628PhosphorylationQTEDPFKSDPFKGAD
CCCCCCCCCCCCCCC
51.3925159151
628 (in isoform 2)Phosphorylation-51.3927251275
632UbiquitinationPFKSDPFKGADPFKG
CCCCCCCCCCCCCCC
59.5921890473
632UbiquitinationPFKSDPFKGADPFKG
CCCCCCCCCCCCCCC
59.5921890473
632UbiquitinationPFKSDPFKGADPFKG
CCCCCCCCCCCCCCC
59.5921890473
632 (in isoform 2)Ubiquitination-59.59-
638UbiquitinationFKGADPFKGDPFQND
CCCCCCCCCCCCCCC
68.7221890473
638UbiquitinationFKGADPFKGDPFQND
CCCCCCCCCCCCCCC
68.7221890473
638UbiquitinationFKGADPFKGDPFQND
CCCCCCCCCCCCCCC
68.7221890473
652PhosphorylationDPFAEQQTTSTDPFG
CCCHHCCCCCCCCCC
23.5528348404
653PhosphorylationPFAEQQTTSTDPFGG
CCHHCCCCCCCCCCC
25.8728348404
654PhosphorylationFAEQQTTSTDPFGGD
CHHCCCCCCCCCCCC
33.9128348404
655PhosphorylationAEQQTTSTDPFGGDP
HHCCCCCCCCCCCCC
45.6728348404
664UbiquitinationPFGGDPFKESDPFRG
CCCCCCCCCCCCCCC
62.7921906983
666PhosphorylationGGDPFKESDPFRGSA
CCCCCCCCCCCCCCC
51.6923663014
672PhosphorylationESDPFRGSATDDFFK
CCCCCCCCCCHHHHH
24.6025159151
672 (in isoform 2)Phosphorylation-24.6027251275
674PhosphorylationDPFRGSATDDFFKKQ
CCCCCCCCHHHHHHH
37.4923663014
679UbiquitinationSATDDFFKKQTKNDP
CCCHHHHHHHHCCCC
43.9221890473
679UbiquitinationSATDDFFKKQTKNDP
CCCHHHHHHHHCCCC
43.9221890473
679 (in isoform 2)Ubiquitination-43.92-
680UbiquitinationATDDFFKKQTKNDPF
CCHHHHHHHHCCCCC
59.03-
680 (in isoform 2)Ubiquitination-59.03-
683UbiquitinationDFFKKQTKNDPFTSD
HHHHHHHCCCCCCCC
57.7821890473
683UbiquitinationDFFKKQTKNDPFTSD
HHHHHHHCCCCCCCC
57.7821890473
683 (in isoform 2)Ubiquitination-57.78-
688PhosphorylationQTKNDPFTSDPFTKN
HHCCCCCCCCCCCCC
37.2928348404
689PhosphorylationTKNDPFTSDPFTKNP
HCCCCCCCCCCCCCC
43.6028348404
689 (in isoform 2)Phosphorylation-43.6027251275
694UbiquitinationFTSDPFTKNPSLPSK
CCCCCCCCCCCCCCC
68.2121890473
694 (in isoform 2)Ubiquitination-68.21-
697PhosphorylationDPFTKNPSLPSKLDP
CCCCCCCCCCCCCCC
63.4125849741
697 (in isoform 2)Phosphorylation-63.4127251275
700PhosphorylationTKNPSLPSKLDPFES
CCCCCCCCCCCCCCC
51.6630576142
701UbiquitinationKNPSLPSKLDPFESS
CCCCCCCCCCCCCCC
55.7721890473
701UbiquitinationKNPSLPSKLDPFESS
CCCCCCCCCCCCCCC
55.7721890473
701UbiquitinationKNPSLPSKLDPFESS
CCCCCCCCCCCCCCC
55.7721890473
701 (in isoform 2)Ubiquitination-55.77-
707PhosphorylationSKLDPFESSDPFSSS
CCCCCCCCCCCCCCC
40.1825159151
707 (in isoform 2)Phosphorylation-40.1827251275
708PhosphorylationKLDPFESSDPFSSSS
CCCCCCCCCCCCCCC
41.9525159151
712PhosphorylationFESSDPFSSSSVSSK
CCCCCCCCCCCCCCC
34.4028450419
713PhosphorylationESSDPFSSSSVSSKG
CCCCCCCCCCCCCCC
27.3230108239
714PhosphorylationSSDPFSSSSVSSKGS
CCCCCCCCCCCCCCC
33.2925159151
714 (in isoform 2)Phosphorylation-33.2927251275
715PhosphorylationSDPFSSSSVSSKGSD
CCCCCCCCCCCCCCC
28.1528450419
717PhosphorylationPFSSSSVSSKGSDPF
CCCCCCCCCCCCCCC
28.4230278072
717 (in isoform 2)Phosphorylation-28.4227251275
718PhosphorylationFSSSSVSSKGSDPFG
CCCCCCCCCCCCCCC
38.5930108239
719UbiquitinationSSSSVSSKGSDPFGT
CCCCCCCCCCCCCCC
55.73-
732PhosphorylationGTLDPFGSGSFNSAE
CCCCCCCCCCCCCCC
31.4826657352
734PhosphorylationLDPFGSGSFNSAEGF
CCCCCCCCCCCCCCC
23.9728270605
734 (in isoform 2)Phosphorylation-23.9727251275
737PhosphorylationFGSGSFNSAEGFADF
CCCCCCCCCCCCCCH
26.2028270605
745PhosphorylationAEGFADFSQMSKPPP
CCCCCCHHHCCCCCC
26.0628270605
748PhosphorylationFADFSQMSKPPPSGP
CCCHHHCCCCCCCCC
34.0828270605
772PhosphorylationFSDDPFKSKQDTPAL
CCCCCCCCCCCCCCC
35.6123312004
776PhosphorylationPFKSKQDTPALPPKK
CCCCCCCCCCCCCCC
14.1528348404
782AcetylationDTPALPPKKPAPPRP
CCCCCCCCCCCCCCC
70.247674313
783AcetylationTPALPPKKPAPPRPK
CCCCCCCCCCCCCCC
52.787674325
793PhosphorylationPPRPKPPSGKSTPVS
CCCCCCCCCCCCCHH
68.3430278072
793 (in isoform 2)Phosphorylation-68.3427251275
796PhosphorylationPKPPSGKSTPVSQLG
CCCCCCCCCCHHHCC
41.2830206219
796 (in isoform 2)Phosphorylation-41.2827251275
797PhosphorylationKPPSGKSTPVSQLGS
CCCCCCCCCHHHCCC
31.0621082442
800PhosphorylationSGKSTPVSQLGSADF
CCCCCCHHHCCCCCC
22.3822199227
804PhosphorylationTPVSQLGSADFPEAP
CCHHHCCCCCCCCCC
33.0028464451
821PhosphorylationFQPLGADSGDPFQSK
CCCCCCCCCCCCCCC
44.5626074081
827PhosphorylationDSGDPFQSKKGFGDP
CCCCCCCCCCCCCCC
36.3926074081
828UbiquitinationSGDPFQSKKGFGDPF
CCCCCCCCCCCCCCC
46.2421890473
828UbiquitinationSGDPFQSKKGFGDPF
CCCCCCCCCCCCCCC
46.2421890473
828 (in isoform 2)Ubiquitination-46.24-
829UbiquitinationGDPFQSKKGFGDPFS
CCCCCCCCCCCCCCC
65.7921890473
829UbiquitinationGDPFQSKKGFGDPFS
CCCCCCCCCCCCCCC
65.7921890473
829 (in isoform 2)Ubiquitination-65.79-
838UbiquitinationFGDPFSGKDPFVPSS
CCCCCCCCCCCCCCH
62.1121890473
838UbiquitinationFGDPFSGKDPFVPSS
CCCCCCCCCCCCCCH
62.1121890473
838 (in isoform 2)Ubiquitination-62.11-
844PhosphorylationGKDPFVPSSAAKPSK
CCCCCCCCHHCCCCC
27.5728555341
845PhosphorylationKDPFVPSSAAKPSKA
CCCCCCCHHCCCCCC
26.6125159151
848UbiquitinationFVPSSAAKPSKASAS
CCCCHHCCCCCCCCC
49.9221890473
848UbiquitinationFVPSSAAKPSKASAS
CCCCHHCCCCCCCCC
49.9221890473
848 (in isoform 2)Ubiquitination-49.92-
851UbiquitinationSSAAKPSKASASGFA
CHHCCCCCCCCCCCC
55.69-
851 (in isoform 2)Ubiquitination-55.69-
853 (in isoform 2)Phosphorylation-27.0627251275
855 (in isoform 2)Phosphorylation-31.7627251275
861 (in isoform 2)Phosphorylation-28.8527251275
862 (in isoform 2)Phosphorylation-21.9827251275
904Ubiquitination-----------------------------------------------
-----------------------------------------------
21890473
904 (in isoform 2)Ubiquitination--

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of EP15R_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of EP15R_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of EP15R_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
AGFG1_HUMANAGFG1genetic
10613896
UBQL1_HUMANUBQLN1physical
16159959
BIRC6_HUMANBIRC6physical
22863883
CND3_HUMANNCAPGphysical
22863883
PRP4_HUMANPRPF4physical
22863883
ZZEF1_HUMANZZEF1physical
22863883
AGFG2_HUMANAGFG2genetic
10613896
DCAF7_HUMANDCAF7physical
27173435
UBP15_HUMANUSP15physical
27173435
JIP4_HUMANSPAG9physical
27173435
MCM2_HUMANMCM2physical
27173435
MCM4_HUMANMCM4physical
27173435
MCM6_HUMANMCM6physical
27173435
NS1BP_HUMANIVNS1ABPphysical
27173435
SMC1A_HUMANSMC1Aphysical
27173435
GAPD1_HUMANGAPVD1physical
27173435
ANK3_HUMANANK3physical
27173435
SBNO1_HUMANSBNO1physical
27173435
SMC3_HUMANSMC3physical
27173435
CD11A_HUMANCDK11Aphysical
27173435
SOX4_HUMANSOX4physical
27173435
HSF1_HUMANHSF1physical
27173435
PLK1_HUMANPLK1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of EP15R_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-229; SER-238 AND SER-255, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-255; SER-560;THR-577 AND THR-797, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-229; SER-238 AND SER-255, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-366; SER-371 ANDSER-374, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND SER-793, ANDMASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND MASSSPECTROMETRY.
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry.";
Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.;
Anal. Chem. 76:2763-2772(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241; SER-244 ANDSER-255, AND MASS SPECTROMETRY.

TOP